These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37182804)
41. Self-assembled metal-phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy. Zhang X; Zong Q; Lin T; Ullah I; Jiang M; Chen S; Tang W; Guo Y; Yuan Y; Du J Biomater Sci; 2024 Jul; 12(14):3649-3658. PubMed ID: 38857014 [TBL] [Abstract][Full Text] [Related]
42. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System. Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660 [TBL] [Abstract][Full Text] [Related]
43. Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy. Xiong Y; Wang Z; Wang Q; Deng Q; Chen J; Wei J; Yang X; Yang X; Li Z Theranostics; 2022; 12(2):944-962. PubMed ID: 34976222 [No Abstract] [Full Text] [Related]
44. Intelligent triggering of nanomicelles based on a ROS-activated anticancer prodrug and photodynamic therapy (PDT)-synergistic therapy for lung cancers. Chen L; Xu R; Ding Y; Wang C; Zhang S; Sun Z; Chen Y; Mi Y; Gao M; Ma X; Li L Eur J Med Chem; 2022 Nov; 241():114622. PubMed ID: 35952401 [TBL] [Abstract][Full Text] [Related]
45. Self-boosting stimulus activation of a polyprodrug with cascade amplification for enhanced antitumor efficacy. Zong Q; Xiao X; Li J; Yuan Y Biomater Sci; 2022 Jul; 10(15):4228-4234. PubMed ID: 35758299 [TBL] [Abstract][Full Text] [Related]
46. Tyrosinase-activated prodrug nanomedicine as oxidative stress amplifier for melanoma-specific treatment. Pu Y; Zhou B; Xiang H; Wu W; Yin H; Yue W; Yin Y; Li H; Chen Y; Xu H Biomaterials; 2020 Nov; 259():120329. PubMed ID: 32836058 [TBL] [Abstract][Full Text] [Related]
47. Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth. Kang X; Wang Q; Wu S; Wang C; Annaji M; Huang CH; Shen J; Chen P; Babu RJ Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238613 [TBL] [Abstract][Full Text] [Related]
48. A PEGylated alternating copolymeric prodrug of sulfur dioxide with glutathione responsiveness for Irinotecan delivery. Zhang Y; Zhang H; He P; Yi X; Liu X; Xiao C J Mater Chem B; 2021 Jan; 9(1):187-194. PubMed ID: 33237120 [TBL] [Abstract][Full Text] [Related]
49. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Chiang YT; Yen YW; Lo CL Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788 [TBL] [Abstract][Full Text] [Related]
50. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy. Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291 [TBL] [Abstract][Full Text] [Related]
51. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment. Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895 [TBL] [Abstract][Full Text] [Related]
52. One-Pot Synthesis of pH/Redox Responsive Polymeric Prodrug and Fabrication of Shell Cross-Linked Prodrug Micelles for Antitumor Drug Transportation. Li L; Li D; Zhang M; He J; Liu J; Ni P Bioconjug Chem; 2018 Aug; 29(8):2806-2817. PubMed ID: 30005157 [TBL] [Abstract][Full Text] [Related]
53. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy. Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311 [TBL] [Abstract][Full Text] [Related]
54. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy. Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843 [TBL] [Abstract][Full Text] [Related]
55. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy. He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704 [TBL] [Abstract][Full Text] [Related]
56. Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy. Yoo W; Yoo D; Hong E; Jung E; Go Y; Singh SVB; Khang G; Lee D J Control Release; 2018 Jan; 269():235-244. PubMed ID: 29146242 [TBL] [Abstract][Full Text] [Related]
57. A mitochondria-targeting ROS-activated nanoprodrug for self-augmented antitumor oxidation therapy. Zeng Z; Luo Y; Xu X; Shan T; Chen M; Huang Z; Huang Y; Zhao C J Control Release; 2023 Jul; 359():415-427. PubMed ID: 37290720 [TBL] [Abstract][Full Text] [Related]
58. GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy. Zhu P; Luo W; Qian J; Meng C; Shan W; Xu Z; Zhang W; Liu X; Ling Y Molecules; 2021 Sep; 26(19):. PubMed ID: 34641443 [TBL] [Abstract][Full Text] [Related]
59. Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress. Zhao H; Li Y; Shi H; Niu M; Li D; Zhang Z; Feng Q; Zhang Y; Wang L J Control Release; 2022 Dec; 352():909-919. PubMed ID: 36370878 [TBL] [Abstract][Full Text] [Related]
60. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy. Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]